Login / Signup

Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study.

Itaru MiuraKei WatabeReiko SakaguchiKeisuke OkamotoHidenori Maruyama
Published in: Neuropsychiatric disease and treatment (2022)
In patients with acute schizophrenia treated with lurasidone 40 mg/d, increasing the dose to 80 mg/d was well tolerated, and was associated with greater improvement in PANSS subscale scores compared to continued treatment with a dose of 40 mg/d.
Keyphrases
  • randomized controlled trial
  • systematic review
  • bipolar disorder